Different Effects of Tolvaptan in Patients with Idiopathic Membranous Nephropathy with Nephrotic Syndrome-Reference-Cited by-同舟云学术

Different Effects of Tolvaptan in Patients with Idiopathic Membranous Nephropathy with Nephrotic Syndrome

Published:2017 Issue:2 Volume:56 Page:191-196
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Tanaka Atsushi¹,Nakamura Tsukasa²,Sato Eiichi²,Ueda Yoshihiko³,Node Koichi¹

Affiliation:

1. Deaprtment of Cardiovascular Medicine, Saga University, Japan

2. Division of Nephrology, Department of Internal Medicine, Shinmatsudo Central General Hospital, Japan

3. Department of Pathology, Koshigaya Hospital, Dokkyo University School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/2/56_56.7539/_pdf

Reference16 articles.

1. 1. Imamura T, Kinugawa K, Fujino T, et al. Increased urine aquaporin-2 relative to plasma arginine vasopressin is a novel marker of response to tolvaptan in patients with decompensated heart failure. Circ J 78: 2240-2249, 2014.

2. 2. Imamura T, Kinugawa K. Urine aquaporin-2: a promising marker of response to the arginine vasopressin type-2 antagonist, tolvaptan in patients with congestive heart failure. Int J Mol Sci 17: pii: E105, 2016.

3. 3. Yang CJ, Yang J, Yang J, Fan ZX. Arginine vasopressin antagonist tolvaptan in the treatment of heart failure: a meta-analysis of randomized controlled trials. Int J Clin Exp Med 8: 22117-22128, 2015.

4. 4. Imamura T, Kinugawa K, Shiga T, et al. Novel criteria of urine osmolality effectively predict response to tolvaptan in decompensated heart failure patients: association between non-responders and chronic kidney disease. Circ J 77: 397-404, 2013.

5. 5. Tanaka A, Katsuno T, Ozaki T, et al. The efficacy of tolvaptan as a diuretic for chronic kidney disease patients. Acta Cardiol 70: 217-223, 2015.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteasuria: The Link between Physiopathogenesis and Edema Management in Nephrotic Syndrome?;Novel Topics in the Diagnosis, Treatment, and Follow-Up of Nephritis, Nephrotic Syndrome, and Nephrosis [Working Title];2022-11-10

2. Mechanisms and management of edema in pediatric nephrotic syndrome;Pediatric Nephrology;2020-11-20

3. Expression of aquaporin-2 in the collecting duct and responses to tolvaptan;CEN Case Reports;2020-08-10

4. Tolvaptan therapy to treat severe hyponatremia in pediatric nephrotic syndrome;Pediatric Nephrology;2020-03-30

5. EXPRESSION OF THE SERUM TNFR1 AND TNFR2IN PATIENTS WITH IDIOPATHIC MEMBRANOUS NEUHROPATHY AND THEIR RELATIONSHIP WITH CLINICOPATHOLOGICAL PARAMETERS AND PROGNOSIS;ACTA MEDICA MEDITERR;2020